» Articles » PMID: 17105892

Right Ventricular Reverse Remodelling After Sildenafil in Pulmonary Arterial Hypertension

Overview
Journal Heart
Date 2006 Nov 16
PMID 17105892
Citations 14
Authors
Affiliations
Soon will be listed here.
Citing Articles

Establishing minimally important differences for cardiac MRI end-points in pulmonary arterial hypertension.

Alabed S, Garg P, Alandejani F, Dwivedi K, Maiter A, Karunasaagarar K Eur Respir J. 2023; 62(2).

PMID: 37414419 PMC: 10397469. DOI: 10.1183/13993003.02225-2022.


Allopurinol in Patients with Pulmonary Hypertension Associated with Chronic Lung Disease.

Liu-Shiu-Cheong P, Lipworth B, Weir-McCall J, Houston J, Struthers A Int J Chron Obstruct Pulmon Dis. 2020; 15:2015-2024.

PMID: 32904701 PMC: 7457596. DOI: 10.2147/COPD.S260917.


Emerging role of cardiovascular magnetic resonance imaging in the management of pulmonary hypertension.

Aryal S, Sharifov O, Lloyd S Eur Respir Rev. 2020; 29(156).

PMID: 32620585 PMC: 9488921. DOI: 10.1183/16000617.0138-2019.


Reversal of echocardiographic right-sided heart pathology in a dog with severe pulmonary hypertension: a case report.

McMahon P, Saelinger C Vet Med (Auckl). 2018; 6:211-218.

PMID: 30101108 PMC: 6067776. DOI: 10.2147/VMRR.S84181.


Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial.

Vizza C, Jansa P, Teal S, Dombi T, Zhou D BMC Cardiovasc Disord. 2017; 17(1):239.

PMID: 28874133 PMC: 5586020. DOI: 10.1186/s12872-017-0674-3.


References
1.
. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1):111-7. DOI: 10.1164/ajrccm.166.1.at1102. View

2.
Roeleveld R, Vonk-Noordegraaf A, Marcus J, Bronzwaer J, Marques K, Postmus P . Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension. Chest. 2004; 125(2):572-9. DOI: 10.1378/chest.125.2.572. View

3.
Wilkins M, Paul G, Strange J, Tunariu N, Gin-Sing W, Banya W . Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study. Am J Respir Crit Care Med. 2005; 171(11):1292-7. DOI: 10.1164/rccm.200410-1411OC. View

4.
Takimoto E, Champion H, Li M, Belardi D, Ren S, Rodriguez E . Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med. 2005; 11(2):214-22. DOI: 10.1038/nm1175. View

5.
Hoeper M, Faulenbach C, Golpon H, Winkler J, Welte T, Niedermeyer J . Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension. Eur Respir J. 2004; 24(6):1007-10. DOI: 10.1183/09031936.04.00051104. View